CVR: 44074214
DKK -1,201,246
Gross profit
Net result: DKK -1,847,358
MTC 2008 HOLDING ApS, CTH Holding Invest ApS
3 more
CVR · view ownership and management
Name registered: Incipiam Pharma ApS
CVR · 23/05/2023
View the full event history
Incipiam Pharma ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Casper Tind Hansen. The company's owners include MTC 2008 HOLDING ApS, CTH Holding Invest ApS and Bondo Hansen Holding ApS. In 2025, the company reported a gross profit of DKK -1,201,246 and a net result of DKK -1,847,358. Equity in the 2025 report amounted to DKK -1,948,853.
Selskabets formål er at udføre aktiviteter relaterede til forskning og udvikling rettet mod fremstilling og kommercialisering af lægemidler inden for cardio-metabolske sygdomme og andre sygdomstilstande, og andre med lægemiddel-udvikling relaterede aktiviteter, samt at yde konsulentydelser til selskaber, som er beskæftigede indenfor selskabets hovedformål.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningIncipiam Pharma ApS was founded on 23 May 2023.
Incipiam Pharma ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Incipiam Pharma ApS include MTC 2008 HOLDING ApS, CTH Holding Invest ApS and Bondo Hansen Holding ApS.
In 2025, Incipiam Pharma ApS reported a gross profit of DKK -1,201,246.
The management of Incipiam Pharma ApS consists of Casper Tind Hansen.
Incipiam Pharma ApS is located at c/o H. Lundbeck A/S, Ottiliavej 9, 2500 Valby.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 42720470, new email: [email protected] (March 30, 2026).
Incipiam Pharma ApS has published its annual report for 2025. Gross profit came to DKK -1,201,246, and the net result was DKK -1,847,358.
As of March 27, 2026, EY Godkendt Revisionspartnerselskab has been appointed auditor of Incipiam Pharma ApS.
Address changed to Ottiliavej 9 9, 2500 Valby (February 22, 2026).
Contact info changed: new phone: 42720470, new email: [email protected] (February 22, 2026).
Incipiam Pharma ApS has published its interim report for the period January 1, 2024 – September 30, 2024.
Incipiam Pharma ApS has published its interim report for the period May 23, 2023 – December 31, 2023.
As of May 23, 2023, Casper Tind Hansen is registered as adm. dir. of Incipiam Pharma ApS.
As of May 23, 2023, MTC 2008 HOLDING ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, CTH Holding Invest ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Bondo Hansen Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Gerhart-Hines Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 20%.
As of May 23, 2023, Receptor Holding ApS is registered as an owner of Incipiam Pharma ApS with an ownership share of 10%.
Incipiam Pharma ApS was founded on May 23, 2023.
Companies in the same industry and area
CVR 37598194
CVR 46133684
CVR 46429931
CVR 45599124
CVR 43917897
